Sanofi Reports Uninspiring Q4 Sales Amid Skepticism On Dupixent’s COPD Potential

Revenues Fall Short Of Consensus

Woman with one thumb up and one thumb down against pink background, represents mixed views
The Mixed Results For Sanofi Left Analysts Lukewarm • Source: Shutterstock

More from Earnings

More from Business